This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense鈥�
- Investigator
- Jonathan A Chatzkel
- Ages
- 18 Years - N/A
- Sexes
- Male